- Report
- January 2026
- 187 Pages
Global
From €3504EUR$3,939USD£3,037GBP
- Report
- October 2025
- 100 Pages
Global
From €2001EUR$2,250USD£1,735GBP
€2668EUR$3,000USD£2,313GBP
- Report
- November 2025
Global
From €4358EUR$4,900USD£3,777GBP
- Report
- July 2025
Global
From €4358EUR$4,900USD£3,777GBP
From €4358EUR$4,900USD£3,777GBP
From €4358EUR$4,900USD£3,777GBP
- Report
- January 2026
- 181 Pages
Global
From €3504EUR$3,939USD£3,037GBP
- Report
- August 2025
- 194 Pages
Global
From €3504EUR$3,939USD£3,037GBP
- Report
- August 2025
- 149 Pages
Global
From €2668EUR$2,999USD£2,312GBP
- Report
- September 2025
Global
From €4358EUR$4,900USD£3,777GBP
- Report
- May 2025
- 100 Pages
Global
From €4358EUR$4,900USD£3,777GBP
- Report
- January 2026
- 377 Pages
Global
From €5204EUR$5,850USD£4,510GBP
- Report
- January 2026
- 182 Pages
Global
From €5204EUR$5,850USD£4,510GBP
- Report
- January 2026
- 383 Pages
Global
From €5204EUR$5,850USD£4,510GBP
- Report
- January 2026
- 271 Pages
Global
From €5204EUR$5,850USD£4,510GBP
- Report
- January 2026
- 296 Pages
Global
From €5204EUR$5,850USD£4,510GBP
- Report
- January 2026
- 377 Pages
Global
From €5204EUR$5,850USD£4,510GBP
- Report
- November 2025
- 180 Pages
Global
From €3504EUR$3,939USD£3,037GBP
- Report
- October 2025
- 180 Pages
Global
From €3504EUR$3,939USD£3,037GBP
- Report
- August 2025
- 195 Pages
Global
From €3504EUR$3,939USD£3,037GBP

The Autoimmune Disease market within the context of Allergy and Immunology is a rapidly growing field of medical research and treatment. Autoimmune diseases are caused by an overactive immune system, which leads to the body attacking its own healthy cells and tissues. Common autoimmune diseases include rheumatoid arthritis, lupus, multiple sclerosis, and type 1 diabetes. Treatment for autoimmune diseases typically involves immunosuppressive drugs, which reduce the activity of the immune system, and biologics, which target specific parts of the immune system.
In recent years, the development of new treatments for autoimmune diseases has been a major focus of research and development in the Allergy and Immunology field. Companies in this market are focused on developing new treatments, such as monoclonal antibodies, small molecule drugs, and gene therapies. Examples of companies in this market include AbbVie, Amgen, Biogen, Celgene, Gilead, and Regeneron. Show Less Read more